Squamous cell carcinoma of the head and neck (SCCHN) is among the most prevalent
cancer types worldwide. Despite multimodal therapeutic approaches that include surgical …

Boron neutron capture therapy (BNCT) is a re-emerging therapy with the ability to selectively
kill tumor cells. After the boron delivery agents enter the tumor tissue and enrich the tumor …

Background. Over the past decades, lots of advance have occurred in the prevention,
diagnosis, and treatment of head and neck cancer (HNC). However, the contemporaneous …

Objective Squamous cell carcinomas (SCCs) with shared etiology, histological
characteristics, and certain risk factors represent the most common solid cancers. This study …

Cancer cell metabolism including aerobic glycolysis, amino acid and fatty acid metabolism,
has been extensively studied. Metabolic reprogramming is a major hallmark of cancer …

Background: Head and neck squamous cell carcinoma (HNSCC) is the seventh most
common type of cancer worldwide. Its highly aggressive and heterogeneous nature and …

The tyrosine kinase inhibitor (TKI) sorafenib continues to be the anchor drug in the treatment
of advanced stage hepatocellular carcinoma (HCC). Other TKIs as well as immune …

Background Human papillomavirus targets the skin and mucous membranes, producing
benign hyperplastic lesions and precancerous and cancerous lesions. An increasing …

Nasopharyngeal carcinoma (NPC) is an epithelial tumor, which develops most frequently
from the lateral pharyngeal recess and holds some complex epidemiological characteristics …

Hepatocellular carcinoma (HCC) represents the third cause of cancer death in men
worldwide, and its increasing incidence can be explained by the increasing occurrence of …